-transparent.png){kind=logo}
Epidemiological studies suggest that about 3.5% of the adult United States population meet criteria for panic disorder, and that an additional 2-5% suffer from agoraphobia with or without panic. Both biological and behavioral models have been proposed to elucidate the nature of this disorder. The authors review research findings regarding these models, as well as pharmacological and cognitive-behavioral treatment approaches. The complexity of factors contributing to the disorder suggests the need for an integrated treatment approach involving considerations of combination drug therapy and psychosocial interventions.
Related Publications
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
January 1992,
The American journal of medicine,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
January 1996,
Bulletin of the Menninger Clinic,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
January 1992,
Bulletin of the Menninger Clinic,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
July 1984,
American journal of psychotherapy,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
March 1995,
Der Nervenarzt,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
April 1989,
The American journal of orthopsychiatry,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
January 1997,
The Journal of clinical psychiatry,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
February 2005,
American family physician,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
January 1992,
Advances in biochemical psychopharmacology,
J F Rosenbaum, and
R A Pollock, and
M W Otto, and
M H Pollack
May 1992,
Rhode Island medicine,
